|
| 36604748 | The gut microbiota in multiple sclerosis varies with disease activity. | | 2023 |
| 38094990 | Neurofilament light chain levels in serum among a large mixed memory clinic cohort: Confounders and diagnostic usefulness. | | 2023 |
| 36586351 | Dimethyl fumarate treatment of primary progressive multiple sclerosis: results of an open-label extension study. | | 2023 |
| 37337838 | The peripheral endocannabinoid system and its association with biomarkers of inflammation in untreated patients with multiple sclerosis. | | 2023 |
| 36773010 | Cluster headache polygenetic risk and known functional variants of CYP3A4 are not associated with treatment response. | | 2023 |
| 36761410 | Aerobic exercise does not affect serum neurofilament light in patients with mild Alzheimer's disease. | | 2023 |
| 34386002 | Methylation and Gene Expression in Relation to the Multiple Sclerosis-Associated Gene Variant rs2104286 and Soluble IL-2Rα in CD8 T Cells. | Frontiers in Immunology | 2021 |
| 32202196 | Exposure to passive smoking during adolescence is associated with an increased risk of developing multiple sclerosis. | Multiple Sclerosis Journal | 2021 |
| 33591593 | Neutrophil-to-lymphocyte ratio and CRP as biomarkers in multiple sclerosis: A systematic review. | Acta Neurologica Scandinavica | 2021 |
| 34247104 | Circulating levels of tight junction proteins in multiple sclerosis: Association with inflammation and disease activity before and after disease modifying therapy. | Multiple Sclerosis and Related Disorders | 2021 |
| 34025661 | Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls. | Frontiers in Immunology | 2021 |
| 34304016 | Biomarkers of systemic inflammation, soluble IL-2Rα and the multiple sclerosis-associated IL2RA SNP rs2104286 in healthy subjects and multiple sclerosis patients. | Multiple Sclerosis and Related Disorders | 2021 |
| 34678704 | Smoking, cardiovascular risk factors and LRP2 gene variation: Associations with disease severity, cognitive function and brain structure in primary progressive multiple sclerosis. | Multiple Sclerosis and Related Disorders | 2021 |
| 34399707 | The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey. | BMC Neurology | 2021 |
| 32679525 | Multiplex assessment of cerebrospinal fluid biomarkers in multiple sclerosis. | Multiple Sclerosis and Related Disorders | 2020 |
| 33584638 | Pregnancy-Induced Changes in microRNA Expression in Multiple Sclerosis. | Frontiers in Immunology | 2020 |
| 32980645 | Biomarkers of inflammation and epithelial barrier function in multiple sclerosis. | Multiple Sclerosis and Related Disorders | 2020 |
| 31242590 | Relationship between Multiple Sclerosis-Associated Risk Allele Variants and Circulating T Cell Phenotypes in Healthy Genotype-Selected Controls. | Cells | 2019 |
| 31655423 | Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis. | Journal of Neuroimmunology | 2019 |
| 30124094 | Alcohol consumption in adolescence is associated with a lower risk of multiple sclerosis in a Danish cohort. | Multiple Sclerosis Journal | 2019 |
| 30457060 | Evidence for oestrogen sensitivity in perinatal depression: pharmacological sex hormone manipulation study. | British Journal of Psychiatry | 2019 |
| 30070595 | Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis. | Multiple Sclerosis Journal | 2019 |
| 30245027 | GPR15 T cells are Th17 like, increased in smokers and associated with multiple sclerosis. | Journal of Autoimmunity | 2019 |
| 30427062 | Short-chain fatty acids and gut microbiota in multiple sclerosis. | Acta Neurologica Scandinavica | 2019 |
| 30917537 | IL-6, IL-12, and IL-23 STAT-Pathway Genetic Risk and Responsiveness of Lymphocytes in Patients with Multiple Sclerosis. | Cells | 2019 |
| 31129415 | Illegal cannabis use is common among Danes with multiple sclerosis. | Multiple Sclerosis and Related Disorders | 2019 |
| 30852181 | Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation. | Journal of Neuroimmunology | 2019 |
| 31428180 | The transcriptome of peripheral blood mononuclear cells in patients with clinical subtypes of late age-related macular degeneration. | Immunity and Ageing | 2019 |
| 29343473 | Smoking affects the interferon beta treatment response in multiple sclerosis. | Neurology | 2018 |
| 29921915 | DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis. | Nat Commun | 2018 |
| 30515298 | The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis. | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2018 |
| 29270986 | Bone microarchitecture and bone mineral density in multiple sclerosis. | Acta Neurologica Scandinavica | 2018 |
| 28179539 | Smoking reduces circulating CD26CD161 MAIT cells in healthy individuals and patients with multiple sclerosis. | Journal of Leukocyte Biology | 2017 |
| 28511943 | Relationship between soluble CD25 and gene expression in healthy individuals and patients with multiple sclerosis. | Cytokine | 2017 |
| 28427696 | Genetic burden of MS risk variants distinguish patients from healthy individuals but are not associated with disease activity. | Multiple Sclerosis and Related Disorders | 2017 |
| 28597127 | The interaction between smoking and HLA genes in multiple sclerosis: replication and refinement. | European Journal of Epidemiology | 2017 |
| 27540591 | Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies. | Neurol Genet | 2016 |
| 26395032 | Identification of Suitable Reference Genes for Peripheral Blood Mononuclear Cell Subset Studies in Multiple Sclerosis. | Scandinavian Journal of Immunology | 2016 |
| 26446064 | Association between age at onset of multiple sclerosis and vitamin D level-related factors. | Neurology | 2016 |
| 27645354 | Shift work at young age is associated with increased risk of multiple sclerosis in a Danish population. | Multiple Sclerosis and Related Disorders | 2016 |
| 27919501 | Soluble serum VCAM-1, whole blood mRNA expression and treatment response in natalizumab-treated multiple sclerosis. | Multiple Sclerosis and Related Disorders | 2016 |
| 27919484 | Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab. | Multiple Sclerosis and Related Disorders | 2016 |
| 26343388 | Class II HLA interactions modulate genetic risk for multiple sclerosis. | Nat Genet | 2015 |
| 25698173 | Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect. | Multiple Sclerosis Journal | 2015 |
| 25533295 | Genetic and environmental determinants of 25-hydroxyvitamin D levels in multiple sclerosis. | Multiple Sclerosis Journal | 2015 |
| 25738751 | Endogenous interferon-β-inducible gene expression and interferon-β-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis. | PLoS ONE | 2015 |
| 25616667 | Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. | Brain | 2015 |
| 24943672 | Prediction of response to interferon therapy in multiple sclerosis. | Acta Neurologica Scandinavica | 2014 |
| 23668375 | The chemokine receptor CCR5 ο32 allele in natalizumab-treated multiple sclerosis. | Acta Neurologica Scandinavica | 2014 |
| 25037176 | Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general. | Journal of Neuroimmunology | 2014 |